[PDF][PDF] A review of potential pharmacological treatments of COVID-19: An evidence-based perspective

V Kumar, G Vardhan, K Tiwari, P Dhamija - Int J Basic Clin Pharmacol, 2020 - core.ac.uk
Coronaviruses (CoVs) typically manifest as mild to severe respiratory tract infections. No
drug is approved by US food and drug administration (FDA) for the treatment of patients with …

Proposed Pharmacological Treatments for COVID-19: Previously Confirmed Drugs

F Bahoosh Feyzabadi, A Nikjoo… - Pharmaceutical and …, 2022 - pbr.mazums.ac.ir
Background: The outbreak of severe acute respiratory syndrome coronavirus-2, also called
'coronavirus disease 2019'(COVID-19), first appeared in December 2019 in Wuhan, China …

[PDF][PDF] Emerging pharmaceutical treatments of novel COVID-19: a review

A Hussain, J Kaler, AK Dubey - Cureus, 2020 - cureus.com
As a new decade began, COVID-19 quickly gained importance as it became the cause of
the current global pandemic. Research has been focusing on studying the structure of SARS …

Advances in the possible treatment of COVID-19: A review.

P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …

[PDF][PDF] Pharmacological treatments of covid-19-a review

JM Cherumanalil, J Thayyil - Asian J Pharm Clin Res, 2020 - kmctmedicalcollege.org
Now the world stands in the fight against coronavirus disease 2019 (COVID-19), with its
early origin from Wuhan city in China. It has evolved into a global pandemic resulting into a …

Current drugs with potential for treatment of COVID-19: A literature review: Drugs for the treatment process of COVID-19

MII Rabby - Journal of pharmacy & pharmaceutical …, 2020 - journals.library.ualberta.ca
Purpose: SARS-CoV-2 first emerged in China in December 2019 and rapidly spread
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …

[HTML][HTML] Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …

COVID-19: A review of the proposed pharmacological treatments

S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …

Literature-based review of the drugs used for the treatment of COVID-19

M Venkatasubbaiah, PD Reddy… - … medicine research and …, 2020 - Elsevier
COVID-19 is primarily a respiratory disease caused by a newly discovered SARS-CoV-2
virus and identified in the city of Wuhan, China in December 2019. WHO has declared this …

A review of pharmacotherapy for coronavirus disease 2019 (COVID-19).

E Saeedi, M Soodmand, MMA Boojar… - 2020 - cabidigitallibrary.org
The epidemic of COVID-19 and its associated acute respiratory syndrome has posed an
unprecedented challenge in identifying effective drugs to prevent and treat it. Due to the high …